Eva Hesping

Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity.

E. Winzeler, F. Hansen, Andrea Schöler, 2020, European journal of medicinal chemistry.

Structure–Activity and Structure–Toxicity Relationships of Peptoid‐Based Histone Deacetylase Inhibitors with Dual‐Stage Antiplasmodial Activity

E. Winzeler, F. Hansen, T. Kurz, 2019, ChemMedChem.

One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.

E. Winzeler, S. Meister, F. Hansen, 2018, European journal of medicinal chemistry.

A conserved malaria parasite protein required for maintenance of sporozoite cell shape and transmission

J. Dessens, Eva Hesping, E. Hesping, 2022, Molecular microbiology.

QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites.

D. Fairlie, T. Kurz, A. Gorse, 2022, ACS infectious diseases.

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation

T. Kurz, K. Andrews, G. Fisher, 2020, International journal for parasitology. Drugs and drug resistance.